Barclays’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $158K | Buy |
|
|||||
|
2022
Q2 | $69K | Sell |
|
|||||
|
2022
Q1 | $154K | Sell |
|
|||||
|
2021
Q4 | $383K | Buy |
|
|||||
|
2021
Q3 | $220K | Buy |
|
|||||
|
2021
Q2 | $131K | Sell |
|
|||||
|
2021
Q1 | $563K | Buy |
|
|||||
|
2020
Q4 | $271K | Sell |
|
|||||
|
2020
Q3 | $786K | Sell |
|
|||||
|
2020
Q2 | $2.57M | Buy |
|
|||||
|
2020
Q1 | $593K | Sell |
|
|||||
|
2019
Q4 | $1.19M | Buy |
|
|||||
|
2019
Q3 | $124K | Sell |
|
|||||
|
2019
Q2 | $3.08M | Buy |
|
|||||
|
2019
Q1 | $1.8M | Sell |
|
|||||
|
2018
Q4 | $1.35M | Buy |
|
|||||
|
2018
Q3 | $2.2M | Sell |
|
|||||
|
2018
Q2 | $3.62M | Sell |
|
|||||
|
2018
Q1 | $5.12M | Sell |
|
|||||
|
2017
Q4 | $11M | Buy |
|
|||||
|
2017
Q3 | $1.73M | Sell |
|
|||||
|
2017
Q2 | $10.8M | Buy |
|
|||||
|
2017
Q1 | $410K | Sell |
|
|||||
|
2016
Q4 | $13M | Buy |
|
|||||
|
2016
Q3 | $630K | Sell |
|
|||||
|
2016
Q2 | $332K | Sell |
|
|||||
|
2016
Q1 | $638K | Buy |
|
|||||
|
2015
Q4 | $373K | Sell |
|
|||||
|
2015
Q3 | $2.13M | Sell |
|
|||||
|
2015
Q2 | $5.66M | Buy |
|
|||||
|
2015
Q1 | $142K | Buy |
|
|||||
|
2014
Q4 | $94K | Sell |
|
|||||
|
2014
Q3 | $280K | Sell |
|
|||||
|
2014
Q2 | $3.73M | Buy |
|
|||||
|
2014
Q1 | $447K | Sell |
|
|||||
|
2013
Q4 | $645K | Sell |
|
|||||
|
2013
Q3 | $871K | Buy |
|
|||||
|
2013
Q2 | $128K | Buy |
|